^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    ADXGYNAE

    Company:
    Arquer Diagnostics
    Type:
    Laboratory Developed Test
    Related tests:
    Details
    Evidence

    News

    1year
    Evaluation of MCM5 in Postmenopausal Bleeding Patients (clinicaltrials.gov)
    P=N/A; Not yet recruiting --> Recruiting | N=1200 --> 2000
    Enrollment change • Enrollment open
    |
    MCM5 (Minichromosome Maintenance Complex Component 5)
    |
    ADXGYNAE
    2years
    Evaluation of MCM5 in Postmenopausal Bleeding Patients (clinicaltrials.gov)
    P=N/A; N=1200; Not yet recruiting; Sponsor:Arquer Diagnostics Ltd
    New trial
    |
    MCM5 (Minichromosome Maintenance Complex Component 5)
    |
    ADXGYNAE
    over3years
    Detection of MCM5 as a novel non-invasive aid for the diagnosis of endometrial and ovarian tumours. (PubMed, BMC Cancer)
    "MCM5 is a novel sensitive and specific biomarker for the detection of ovarian and endometrial tumours in urine samples, which is likely to have clinical utility as a diagnostic aid."
    Journal
    |
    MCM5 (Minichromosome Maintenance Complex Component 5)
    |
    ADXGYNAE